Clincosm LogoSign in Get a demo

Carcinoma, Non-Small-Cell Lung

Showing NaN - NaN of 48
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse Trial in Worldwide (PF-05082566, rituximab)

Completed
Has Results
  • Lymphoma, Non-Hodgkin
  • +6 more
  • Duarte, California
  • +41 more
Mar 4, 2020

NSCLC Trial in United States (Atezolizumab)

Unknown status
  • Carcinoma, Non-Small-Cell Lung
  • Phoenix, Arizona
  • +12 more
Feb 10, 2020

Tumors, Tumor Metastasis, Melanoma Trial in Worldwide (LY3009120 capsule)

Terminated
Has Results
  • Neoplasms
  • +4 more
  • LY3009120 capsule
  • Scottsdale, Arizona
  • +5 more
Dec 20, 2019

NSCLC Trial in Worldwide (Emibetuzumab, Erlotinib)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Birmingham, Alabama
  • +58 more
Sep 6, 2019

NSCLC, Carcinoma, Renal Cell, Breast Tumors Trial in United States (SGN-2FF, pembrolizumab)

Terminated
  • Carcinoma, Non-Small-Cell Lung
  • +7 more
  • Birmingham, Alabama
  • +10 more
Jul 17, 2019

NSCLC Trial in United States (JNJ-64041757 (Cohort 1A and 1B), JNJ-64041757 (Cohort 2A and 2B))

Terminated
  • Carcinoma, Non-Small-Cell Lung
  • JNJ-64041757 (Cohort 1A and 1B)
  • JNJ-64041757 (Cohort 2A and 2B)
  • Duarte, California
  • +8 more
Nov 21, 2018

Lung Cancer, Small Cell Lung Cancer, NSCLC Trial in Worldwide (Ipilimumab, Placebo, Paclitaxel)

Completed
Has Results
  • Lung Cancer
  • +2 more
  • Birmingham, Alabama
  • +71 more
Jun 18, 2018

NSCLC, Lung Tumors Trial in Worldwide (HKI-272)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasms
  • Los Angeles, California
  • +18 more
Apr 6, 2018

Non-Small-Cell Lung Cancer Stage IIIB, Non-Small-Cell Lung Cancer Stage IV, Non-Small-Cell Lung Cancer Metastatic Trial in

Completed
  • Non-Small-Cell Lung Cancer Stage IIIB
  • +6 more
  • bavituximab
  • +2 more
  • Huntsville, Alabama
  • +160 more
Apr 19, 2017

NSCLC Trial in India, United States (anamorelin HCl, )

Completed
  • Carcinoma, Non-Small-Cell Lung
  • anamorelin HCl
  • placebo
  • Little Rock, Arkansas
  • +32 more
Apr 12, 2017

NSCLC Trial in Aurora, Boston (Dose escalation followed by treatment with MTD)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Dose escalation followed by treatment with MTD
  • Aurora, Colorado
  • +1 more
Dec 8, 2016

NSCLC Trial in Worldwide (PF-02341066)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Birmingham, Alabama
  • +278 more
Nov 17, 2016

NSCLC Trial in Worldwide (PF-02341066, Pemetrexed, Docetaxel)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Little Rock, Arkansas
  • +263 more
Oct 31, 2016

NSCLC Trial in United States (Paclitaxel and carboplatin)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • Paclitaxel and carboplatin
  • Hot Springs, Arkansas
  • +55 more
Sep 16, 2016

NSCLC Trial in Taiwan, United States (BIBW 2992)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • BIBW 2992
  • Bakersfield, California
  • +29 more
Jul 28, 2016

NSCLC Trial in Worldwide (ZD6474, Paclitaxel, Carboplatin)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • Concord, California
  • +33 more
Aug 24, 2016

NSCLC Trial in Worldwide (MM-121, Erlotinib)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Birmingham, Alabama
  • +37 more
Jul 12, 2016

NSCLC Trial in Los Angeles, Boston, Dallas (Imexon + docetaxel)

Withdrawn
  • Carcinoma, Non-Small-Cell Lung
  • Imexon + docetaxel
  • Los Angeles, California
  • +2 more
Jun 22, 2015

NSCLC Trial in United States (XL184, erlotinib)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • Anchorage, Alaska
  • +12 more
Sep 17, 2013

NSCLC Trial in United States (TLK286, carboplatin, paclitaxel)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • Concord, California
  • +51 more
May 30, 2012

NSCLC, Head and Neck Tumors Trial in United States ([18F]-ML-10 in conjunction with PET imaging)

Unknown status
  • Carcinoma, Non-Small-Cell Lung
  • Head and Neck Neoplasms
  • [18F]-ML-10 in conjunction with PET imaging
  • Boston, Massachusetts
  • +3 more
Dec 16, 2010

NSCLC Trial in Worldwide (Gemcitabine, LY293111, cisplatin)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • Birmingham, Alabama
  • +18 more
Dec 17, 2007

Brain Tumors, NSCLC, Metastases, Tumor Trial in Worldwide (Motexafin Gadolinium)

Completed
  • Brain Neoplasms
  • +2 more
  • Motexafin Gadolinium
  • Phoenix, Arizona
  • +91 more
May 4, 2007